Orbifu Ltd at the Google AI Cancer Symposium

Orbifu Ltd and its founder, Dr. Manoj Bhagat Sharma, PhD, are honored to attend as selected guests at the Google Cloud Cancer AI Symposium 2025. This leading forum convenes global experts in oncology, technology, and research to examine the evolving role of artificial intelligence in cancer care.

​

The symposium provides a valuable opportunity to exchange knowledge on how AI is accelerating progress across the cancer journey. For Orbifu, this attendance marks a major step in the company’s transition to a new biomedical project focused on AI-driven cancer drug delivery, representing a clear continuation and evolution of Dr. Sharma's specialized PhD research.

​

The company’s vision is built upon a strong foundation of published research and work currently under peer review, originating from Dr. Sharma's extensive doctoral study on AI-driven smart drug delivery and biomedical technologies. This includes pioneering work in precision targeted drug carriers for tumor treatment and smart electroactive systems.

​

Orbifu is now merging this foundational knowledge with cutting edge AI smart tech to introduce a new innovation that promises to open a new lifestyle for the medical field. By seamlessly integrating artificial intelligence into cancer drug discovery and delivery, we aim to overcome current treatment barriers, enhance therapeutic effectiveness, and deliver a new standard of personalized patient care.

​

As a selected participant in the prestigious Google for Startups (2025) Cloud Program, we are honored to be part of this important conversation. Dr. Sharma looks forward to learning from fellow participants while contributing Orbifu's unique perspective on how the convergence of materials science and AI is actively reshaping the future of oncology.